Patents by Inventor Werner Siekmann

Werner Siekmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8052969
    Abstract: A method of providing autologous conditioned plasma (ACP) for treatment of connective tissue injuries. The method comprises the steps of: (i) providing an apparatus comprising a centrifuge and a double syringe, the double syringe including an inner syringe body and an outer syringe body; (ii) drawing autologous blood into the outer syringe body; (iii) subjecting the autologous blood to at least one centrifugation step to obtain an autologous conditioned plasma (ACP); (iv) removing, with the inner syringe body, at least a portion of autologous conditioned plasma (ACP) from the outer syringe body; and (v) inject ACP for treatment of various cartilage or tendon damage or diseases.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: November 8, 2011
    Assignee: Arthrex, Inc.
    Inventors: Michael Buhr, Werner Siekmann, Stèphane Naudin
  • Publication number: 20090061460
    Abstract: Test apparatus for detecting an analyte (A) contained in a sample liquid, comprising a dry porous carrier (10), on which a selective binder (12), capable of selectively binding the analyte (A) after the carrier (10) is wetted with the sample fluid, is arranged in a reaction zone (20), wherein furthermore arranged in the reaction zone (20) are: a complex, formed by a biomarker (B) and the first complexed reporter partner of a pair of reporters, interacting to produce an optically detectable signal, of reporter enzyme (E) and reporter substrate (S), and the second, free reporter partner of the pair of reporters, wherein the biomarker (B), in terms of the selectivity of the binding capacity of the selective binder (12), is equivalent to the analyte (A) and competitive therewith and wherein binding of the selective binder (12) to the complexed biomarker (B) impedes the interaction between the complexed and the free reporter partners.
    Type: Application
    Filed: August 28, 2008
    Publication date: March 5, 2009
    Applicant: ANALYTICON BIOTECHNOLOGIES AG
    Inventors: Eloisa Lopez-Calle, Juergen Oberstrass, Werner Siekmann
  • Publication number: 20080166421
    Abstract: A method of providing autologous conditioned plasma (ACP) for treatment of connective tissue injuries. The method comprises the steps of: (i) providing an apparatus comprising a centrifuge and a double syringe, the double syringe including an inner syringe body and an outer syringe body; (ii) drawing autologous blood into the outer syringe body; (iii) subjecting the autologous blood to at least one centrifugation step to obtain an autologous conditioned plasma (ACP); (iv) removing, with the inner syringe body, at least a portion of autologous conditioned plasma (ACP) from the outer syringe body; and (v) inject ACP for treatment of various cartilage or tendon damage or diseases.
    Type: Application
    Filed: December 21, 2007
    Publication date: July 10, 2008
    Inventors: Michael Buhr, Werner Siekmann, Stephane Naudin
  • Publication number: 20010052764
    Abstract: What is described here is a magnetic-field device for stimulating and/or supporting physical functions such as the treatment of fractures, comprising
    Type: Application
    Filed: January 26, 2001
    Publication date: December 20, 2001
    Inventor: Werner Siekmann